Intuitive Surgical, Inc. $ISRG Shares Purchased by IFC Advisors LLC

IFC Advisors LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 722 shares of the medical equipment provider’s stock after purchasing an additional 23 shares during the quarter. IFC Advisors LLC’s holdings in Intuitive Surgical were worth $392,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. RFG Advisory LLC raised its stake in Intuitive Surgical by 4.2% during the second quarter. RFG Advisory LLC now owns 3,374 shares of the medical equipment provider’s stock valued at $1,833,000 after buying an additional 136 shares in the last quarter. Axxcess Wealth Management LLC raised its stake in Intuitive Surgical by 24.0% during the second quarter. Axxcess Wealth Management LLC now owns 11,017 shares of the medical equipment provider’s stock valued at $5,987,000 after buying an additional 2,129 shares in the last quarter. Moran Wealth Management LLC raised its position in shares of Intuitive Surgical by 44.0% during the 2nd quarter. Moran Wealth Management LLC now owns 2,476 shares of the medical equipment provider’s stock worth $1,345,000 after purchasing an additional 757 shares during the period. Cornerstone Wealth Group LLC raised its position in shares of Intuitive Surgical by 20.1% during the 2nd quarter. Cornerstone Wealth Group LLC now owns 764 shares of the medical equipment provider’s stock worth $415,000 after purchasing an additional 128 shares during the period. Finally, NorthRock Partners LLC raised its position in shares of Intuitive Surgical by 0.5% during the 2nd quarter. NorthRock Partners LLC now owns 4,711 shares of the medical equipment provider’s stock worth $2,560,000 after purchasing an additional 25 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $435.73 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market cap of $156.20 billion, a P/E ratio of 60.77, a P/E/G ratio of 4.51 and a beta of 1.61. The stock’s 50 day moving average price is $457.73 and its 200 day moving average price is $497.44.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the company posted $1.78 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. The Goldman Sachs Group dropped their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research report on Wednesday, October 1st. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Evercore ISI dropped their price target on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 7th. Finally, Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $584.76.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 in the last three months. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.